CDKN2A and neoplasm: Additionally, upregulation of tumor suppressors TP53 and CDKN2A may suggest their roles in cell-cycle and DNA-damage check-point functions to prevent EtOH-induced aberrant growth and malignant transformation in esophageal carcinogenesis.